Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Marc van de Wetering

Senior Scientist

Development of organoid technology for pediatric solid tumors.

  • Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids

    • nov. 2024
    • Thomas A, Kluiver, et al
    • Nature communications
  • Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation

    • okt. 2023
    • Lin, Lin, et al
    • Science
  • Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

    • mei 2023
    • Irene, Paassen, et al
    • Oncogene
  • Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivities

    • jan. 2023
    • Thomas, Kluiver, et al
    • bioRxiv
  • Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells

    • jan. 2023
    • Lindy L., Visser, et al
    • Cancer Research Communications
View all publications